SMAD9 and pulmonary arterial hypertension: ALK1 might also phosphorylate SMAD9 (formerly known as SMAD8) and mutations in Smad9 are associated with defective pulmonary vascular remodelling in mice (93) and are a rare cause of pulmonary arterial hypertension in humans (94).